nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Hypokalaemia—Indacaterol—asthma	0.009	0.022	CcSEcCtD
Alvimopan—Hypokalaemia—Orciprenaline—asthma	0.00894	0.0219	CcSEcCtD
Alvimopan—Urinary retention—Theophylline—asthma	0.00781	0.0191	CcSEcCtD
Alvimopan—Hypokalaemia—Theophylline—asthma	0.00747	0.0183	CcSEcCtD
Alvimopan—Connective tissue disorder—Indacaterol—asthma	0.00673	0.0165	CcSEcCtD
Alvimopan—Connective tissue disorder—Fluticasone furoate—asthma	0.00625	0.0153	CcSEcCtD
Alvimopan—Urinary retention—Ipratropium bromide—asthma	0.0062	0.0152	CcSEcCtD
Alvimopan—Flatulence—Zileuton—asthma	0.00596	0.0146	CcSEcCtD
Alvimopan—Malnutrition—Indacaterol—asthma	0.00596	0.0146	CcSEcCtD
Alvimopan—Urinary retention—Aminophylline—asthma	0.00569	0.0139	CcSEcCtD
Alvimopan—Back pain—Pirbuterol—asthma	0.00556	0.0136	CcSEcCtD
Alvimopan—Anaemia—Indacaterol—asthma	0.00551	0.0135	CcSEcCtD
Alvimopan—Hypokalaemia—Aminophylline—asthma	0.00544	0.0133	CcSEcCtD
Alvimopan—Urinary retention—Tiotropium—asthma	0.00536	0.0131	CcSEcCtD
Alvimopan—Back pain—Fluticasone furoate—asthma	0.00535	0.0131	CcSEcCtD
Alvimopan—Back pain—Zafirlukast—asthma	0.00503	0.0123	CcSEcCtD
Alvimopan—Back pain—Beclomethasone—asthma	0.00478	0.0117	CcSEcCtD
Alvimopan—Back pain—Ciclesonide—asthma	0.00458	0.0112	CcSEcCtD
Alvimopan—Quinapril—ACE—asthma	0.00446	0.332	CrCbGaD
Alvimopan—Urinary tract disorder—Ipratropium bromide—asthma	0.00446	0.0109	CcSEcCtD
Alvimopan—Urethral disorder—Ipratropium bromide—asthma	0.00442	0.0108	CcSEcCtD
Alvimopan—Dyspepsia—Zileuton—asthma	0.00435	0.0106	CcSEcCtD
Alvimopan—Connective tissue disorder—Fluticasone Propionate—asthma	0.00429	0.0105	CcSEcCtD
Alvimopan—Connective tissue disorder—Salmeterol—asthma	0.00428	0.0105	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Zileuton—asthma	0.00426	0.0104	CcSEcCtD
Alvimopan—Flatulence—Cromoglicic acid—asthma	0.00424	0.0104	CcSEcCtD
Alvimopan—Constipation—Zileuton—asthma	0.00422	0.0103	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Indacaterol—asthma	0.0042	0.0103	CcSEcCtD
Alvimopan—Dyspepsia—Nedocromil—asthma	0.00416	0.0102	CcSEcCtD
Alvimopan—Hypokalaemia—Formoterol—asthma	0.00414	0.0101	CcSEcCtD
Alvimopan—Hypokalaemia—Arformoterol—asthma	0.00414	0.0101	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Nedocromil—asthma	0.00408	0.00998	CcSEcCtD
Alvimopan—Anaemia—Cromoglicic acid—asthma	0.00397	0.00973	CcSEcCtD
Alvimopan—Hypokalaemia—Salbutamol—asthma	0.00391	0.00957	CcSEcCtD
Alvimopan—Benazepril—ACE—asthma	0.00388	0.289	CrCbGaD
Alvimopan—Flatulence—Ipratropium bromide—asthma	0.00387	0.00947	CcSEcCtD
Alvimopan—Urinary tract disorder—Tiotropium—asthma	0.00385	0.00943	CcSEcCtD
Alvimopan—Connective tissue disorder—Tiotropium—asthma	0.00383	0.00938	CcSEcCtD
Alvimopan—Urethral disorder—Tiotropium—asthma	0.00383	0.00936	CcSEcCtD
Alvimopan—Malnutrition—Fluticasone Propionate—asthma	0.0038	0.0093	CcSEcCtD
Alvimopan—Back pain—Ipratropium bromide—asthma	0.0038	0.0093	CcSEcCtD
Alvimopan—Malnutrition—Salmeterol—asthma	0.00379	0.00928	CcSEcCtD
Alvimopan—Hypokalaemia—Budesonide—asthma	0.00379	0.00927	CcSEcCtD
Alvimopan—Dyspepsia—Zafirlukast—asthma	0.00373	0.00914	CcSEcCtD
Alvimopan—Back pain—Salmeterol—asthma	0.00367	0.00898	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Zafirlukast—asthma	0.00366	0.00896	CcSEcCtD
Alvimopan—Dyspepsia—Ciclesonide—asthma	0.0034	0.00832	CcSEcCtD
Alvimopan—Malnutrition—Tiotropium—asthma	0.0034	0.00831	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ciclesonide—asthma	0.00334	0.00816	CcSEcCtD
Alvimopan—Back pain—Tiotropium—asthma	0.00329	0.00804	CcSEcCtD
Alvimopan—Ketoprofen—CXCL8—asthma	0.00327	0.244	CrCbGaD
Alvimopan—Malnutrition—Flunisolide—asthma	0.00315	0.0077	CcSEcCtD
Alvimopan—Urinary tract disorder—Arformoterol—asthma	0.00311	0.00761	CcSEcCtD
Alvimopan—Urinary tract disorder—Formoterol—asthma	0.00311	0.00761	CcSEcCtD
Alvimopan—Connective tissue disorder—Formoterol—asthma	0.00309	0.00757	CcSEcCtD
Alvimopan—Connective tissue disorder—Arformoterol—asthma	0.00309	0.00757	CcSEcCtD
Alvimopan—Dyspepsia—Cromoglicic acid—asthma	0.00309	0.00756	CcSEcCtD
Alvimopan—Urethral disorder—Formoterol—asthma	0.00309	0.00755	CcSEcCtD
Alvimopan—Urethral disorder—Arformoterol—asthma	0.00309	0.00755	CcSEcCtD
Alvimopan—Urinary tract disorder—Montelukast—asthma	0.00305	0.00745	CcSEcCtD
Alvimopan—Back pain—Flunisolide—asthma	0.00305	0.00745	CcSEcCtD
Alvimopan—Connective tissue disorder—Montelukast—asthma	0.00303	0.00742	CcSEcCtD
Alvimopan—Urethral disorder—Montelukast—asthma	0.00302	0.0074	CcSEcCtD
Alvimopan—Constipation—Cromoglicic acid—asthma	0.003	0.00734	CcSEcCtD
Alvimopan—Urinary tract disorder—Salbutamol—asthma	0.00294	0.00719	CcSEcCtD
Alvimopan—Connective tissue disorder—Salbutamol—asthma	0.00292	0.00715	CcSEcCtD
Alvimopan—Urethral disorder—Salbutamol—asthma	0.00292	0.00713	CcSEcCtD
Alvimopan—Urinary tract disorder—Budesonide—asthma	0.00284	0.00696	CcSEcCtD
Alvimopan—Connective tissue disorder—Budesonide—asthma	0.00283	0.00693	CcSEcCtD
Alvimopan—Back pain—Mometasone—asthma	0.00283	0.00691	CcSEcCtD
Alvimopan—Urethral disorder—Budesonide—asthma	0.00282	0.00691	CcSEcCtD
Alvimopan—Dyspepsia—Ipratropium bromide—asthma	0.00282	0.00691	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Ipratropium bromide—asthma	0.00277	0.00677	CcSEcCtD
Alvimopan—Constipation—Ipratropium bromide—asthma	0.00274	0.00671	CcSEcCtD
Alvimopan—Malnutrition—Formoterol—asthma	0.00274	0.00671	CcSEcCtD
Alvimopan—Malnutrition—Arformoterol—asthma	0.00274	0.00671	CcSEcCtD
Alvimopan—Dyspepsia—Salmeterol—asthma	0.00272	0.00667	CcSEcCtD
Alvimopan—Back pain—Formoterol—asthma	0.00265	0.00649	CcSEcCtD
Alvimopan—Back pain—Arformoterol—asthma	0.00265	0.00649	CcSEcCtD
Alvimopan—Constipation—Salmeterol—asthma	0.00265	0.00648	CcSEcCtD
Alvimopan—Malnutrition—Salbutamol—asthma	0.00259	0.00633	CcSEcCtD
Alvimopan—Dyspepsia—Aminophylline—asthma	0.00259	0.00633	CcSEcCtD
Alvimopan—Flatulence—Salbutamol—asthma	0.00255	0.00624	CcSEcCtD
Alvimopan—Malnutrition—Budesonide—asthma	0.00251	0.00614	CcSEcCtD
Alvimopan—Back pain—Salbutamol—asthma	0.0025	0.00613	CcSEcCtD
Alvimopan—Flatulence—Budesonide—asthma	0.00247	0.00605	CcSEcCtD
Alvimopan—Dyspepsia—Loratadine—asthma	0.00244	0.00598	CcSEcCtD
Alvimopan—Dyspepsia—Tiotropium—asthma	0.00244	0.00597	CcSEcCtD
Alvimopan—Back pain—Budesonide—asthma	0.00243	0.00594	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Loratadine—asthma	0.0024	0.00587	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Tiotropium—asthma	0.00239	0.00586	CcSEcCtD
Alvimopan—Constipation—Loratadine—asthma	0.00238	0.00581	CcSEcCtD
Alvimopan—Constipation—Tiotropium—asthma	0.00237	0.0058	CcSEcCtD
Alvimopan—Anaemia—Budesonide—asthma	0.00232	0.00567	CcSEcCtD
Alvimopan—Dyspepsia—Flunisolide—asthma	0.00226	0.00554	CcSEcCtD
Alvimopan—Constipation—Flunisolide—asthma	0.0022	0.00538	CcSEcCtD
Alvimopan—Hypokalaemia—Hydrocortisone—asthma	0.00219	0.00536	CcSEcCtD
Alvimopan—Dyspepsia—Mometasone—asthma	0.0021	0.00513	CcSEcCtD
Alvimopan—Dyspepsia—Formoterol—asthma	0.00197	0.00482	CcSEcCtD
Alvimopan—Dyspepsia—Arformoterol—asthma	0.00197	0.00482	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Formoterol—asthma	0.00193	0.00473	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Arformoterol—asthma	0.00193	0.00473	CcSEcCtD
Alvimopan—Dyspepsia—Montelukast—asthma	0.00193	0.00472	CcSEcCtD
Alvimopan—Constipation—Formoterol—asthma	0.00191	0.00468	CcSEcCtD
Alvimopan—Constipation—Arformoterol—asthma	0.00191	0.00468	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Montelukast—asthma	0.00189	0.00463	CcSEcCtD
Alvimopan—Hypokalaemia—Dexamethasone—asthma	0.00187	0.00458	CcSEcCtD
Alvimopan—Hypokalaemia—Betamethasone—asthma	0.00187	0.00458	CcSEcCtD
Alvimopan—Dyspepsia—Salbutamol—asthma	0.00186	0.00455	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Salbutamol—asthma	0.00182	0.00446	CcSEcCtD
Alvimopan—Constipation—Salbutamol—asthma	0.00181	0.00442	CcSEcCtD
Alvimopan—Dyspepsia—Budesonide—asthma	0.0018	0.00441	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Budesonide—asthma	0.00177	0.00432	CcSEcCtD
Alvimopan—Constipation—Budesonide—asthma	0.00175	0.00428	CcSEcCtD
Alvimopan—Connective tissue disorder—Hydrocortisone—asthma	0.00164	0.00401	CcSEcCtD
Alvimopan—Hypokalaemia—Prednisone—asthma	0.00163	0.00399	CcSEcCtD
Alvimopan—Connective tissue disorder—Methylprednisolone—asthma	0.00154	0.00376	CcSEcCtD
Alvimopan—Malnutrition—Hydrocortisone—asthma	0.00145	0.00355	CcSEcCtD
Alvimopan—Malnutrition—Methylprednisolone—asthma	0.00136	0.00333	CcSEcCtD
Alvimopan—Back pain—Triamcinolone—asthma	0.00132	0.00323	CcSEcCtD
Alvimopan—Connective tissue disorder—Prednisone—asthma	0.00122	0.00298	CcSEcCtD
Alvimopan—Malnutrition—Prednisone—asthma	0.00108	0.00264	CcSEcCtD
Alvimopan—Dyspepsia—Hydrocortisone—asthma	0.00104	0.00255	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Hydrocortisone—asthma	0.00102	0.0025	CcSEcCtD
Alvimopan—Anaemia—Prednisone—asthma	0.000997	0.00244	CcSEcCtD
Alvimopan—Dyspepsia—Triamcinolone—asthma	0.000981	0.0024	CcSEcCtD
Alvimopan—Dyspepsia—Methylprednisolone—asthma	0.000979	0.0024	CcSEcCtD
Alvimopan—Ketoprofen—PTGS2—asthma	0.000955	0.0711	CrCbGaD
Alvimopan—Dyspepsia—Dexamethasone—asthma	0.00089	0.00218	CcSEcCtD
Alvimopan—Dyspepsia—Betamethasone—asthma	0.00089	0.00218	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dexamethasone—asthma	0.000873	0.00214	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Betamethasone—asthma	0.000873	0.00214	CcSEcCtD
Alvimopan—Ketoprofen—ALB—asthma	0.00085	0.0634	CrCbGaD
Alvimopan—Dyspepsia—Prednisone—asthma	0.000775	0.0019	CcSEcCtD
Alvimopan—Constipation—Prednisone—asthma	0.000753	0.00184	CcSEcCtD
Alvimopan—OPRK1—Signaling by GPCR—ADRB2—asthma	0.000168	0.000291	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CSF2—asthma	0.000167	0.00029	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT6—asthma	0.000167	0.000289	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2RA—asthma	0.000166	0.000288	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KIF3A—asthma	0.000166	0.000287	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDE4A—asthma	0.000166	0.000287	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—KNG1—asthma	0.000166	0.000287	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—BDKRB2—asthma	0.000166	0.000286	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—EDN1—asthma	0.000165	0.000286	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR3—asthma	0.000165	0.000286	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGTR1—asthma	0.000165	0.000285	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—C3—asthma	0.000165	0.000285	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL5—asthma	0.000164	0.000284	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2RB—asthma	0.000164	0.000284	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDE4D—asthma	0.000162	0.000281	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CSF2—asthma	0.000162	0.00028	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL10—asthma	0.000161	0.000279	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NPY—asthma	0.000161	0.000278	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADCY2—asthma	0.00016	0.000277	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL3—asthma	0.00016	0.000276	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—ITPR1—asthma	0.000159	0.000275	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDE4B—asthma	0.000158	0.000274	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—C5—asthma	0.000158	0.000274	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TACR1—asthma	0.000158	0.000274	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL8—asthma	0.000158	0.000274	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ADRB2—asthma	0.000156	0.000271	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PPP2CA—asthma	0.000156	0.00027	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CYSLTR1—asthma	0.000155	0.000269	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGTR2—asthma	0.000155	0.000269	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR5—asthma	0.000153	0.000265	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2RA—asthma	0.000151	0.000261	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—KNG1—asthma	0.000151	0.000261	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EDN1—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—UTS2—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C5AR1—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CMA1—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL11—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VIP—asthma	0.00015	0.00026	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGTR1—asthma	0.00015	0.000259	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—C3—asthma	0.00015	0.000259	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL5—asthma	0.000149	0.000258	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EDNRB—asthma	0.000149	0.000257	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PLA2G4A—asthma	0.000148	0.000257	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—ITPR1—asthma	0.000148	0.000256	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR5—asthma	0.000148	0.000256	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NPS—asthma	0.000147	0.000255	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TAC1—asthma	0.000147	0.000255	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CSF2—asthma	0.000147	0.000254	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL10—asthma	0.000146	0.000253	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2RA—asthma	0.000146	0.000252	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR3—asthma	0.000145	0.00025	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—C3—asthma	0.000144	0.00025	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR3—asthma	0.000144	0.00025	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR4—asthma	0.000144	0.000249	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRB2—asthma	0.000142	0.000246	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT6—asthma	0.000141	0.000244	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NPY—asthma	0.000141	0.000244	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—EDN1—asthma	0.00014	0.000242	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CYBA—asthma	0.00014	0.000242	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL5—asthma	0.000139	0.00024	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2RB—asthma	0.000138	0.00024	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDE4D—asthma	0.000137	0.000237	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PARP1—asthma	0.000137	0.000237	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL5—asthma	0.000137	0.000237	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PPP2CA—asthma	0.000137	0.000237	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CSF2—asthma	0.000137	0.000236	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGTR2—asthma	0.000136	0.000235	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ITPR1—asthma	0.000134	0.000232	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR5—asthma	0.000134	0.000232	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDE4B—asthma	0.000134	0.000231	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C5—asthma	0.000134	0.000231	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TACR1—asthma	0.000134	0.000231	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL8—asthma	0.000134	0.000231	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2RA—asthma	0.000132	0.000229	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BDKRB2—asthma	0.000132	0.000228	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—POMC—asthma	0.000132	0.000228	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—C3—asthma	0.000131	0.000227	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EDNRB—asthma	0.00013	0.000225	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TAC1—asthma	0.000129	0.000223	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NPS—asthma	0.000129	0.000223	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADCY2—asthma	0.000128	0.000221	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL3—asthma	0.000127	0.00022	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EDN1—asthma	0.000127	0.00022	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR3—asthma	0.000127	0.000219	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL5—asthma	0.000126	0.000218	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PLA2G4A—asthma	0.000125	0.000217	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR5—asthma	0.000125	0.000216	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CSF2—asthma	0.000124	0.000215	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2RA—asthma	0.000123	0.000213	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CYBA—asthma	0.000123	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR3—asthma	0.000122	0.000212	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—C3—asthma	0.000122	0.000211	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KNG1—asthma	0.00012	0.000208	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL5—asthma	0.00012	0.000208	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PARP1—asthma	0.00012	0.000208	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—POMC—asthma	0.00012	0.000207	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGTR1—asthma	0.000119	0.000206	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPY—asthma	0.000119	0.000206	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL2—asthma	0.000117	0.000203	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6R—asthma	0.000117	0.000202	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL10—asthma	0.000117	0.000202	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—RHOA—asthma	0.000116	0.000201	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BDKRB2—asthma	0.000116	0.0002	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PPP2CA—asthma	0.000116	0.0002	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—asthma	0.000116	0.0002	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR2—asthma	0.000115	0.000199	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NTRK1—asthma	0.000114	0.000198	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR5—asthma	0.000113	0.000196	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB2—asthma	0.000113	0.000196	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADCY2—asthma	0.000112	0.000194	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2RA—asthma	0.000112	0.000193	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL3—asthma	0.000112	0.000193	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—C3—asthma	0.000111	0.000192	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDNRB—asthma	0.00011	0.000191	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TAC1—asthma	0.000109	0.000189	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPS—asthma	0.000109	0.000189	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ITPR1—asthma	0.000107	0.000185	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR3—asthma	0.000107	0.000185	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RHOA—asthma	0.000105	0.000182	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KNG1—asthma	0.000105	0.000182	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—asthma	0.000105	0.000182	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGTR1—asthma	0.000105	0.000181	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CYBA—asthma	0.000104	0.000179	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL2—asthma	0.000103	0.000178	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6R—asthma	0.000102	0.000177	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—asthma	0.000102	0.000177	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CD86—asthma	0.000102	0.000176	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—asthma	0.000102	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—RHOA—asthma	0.000102	0.000176	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PARP1—asthma	0.000101	0.000175	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL5—asthma	0.000101	0.000175	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EDN1—asthma	0.000101	0.000175	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—asthma	0.0001	0.000174	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NTRK1—asthma	0.0001	0.000174	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PLA2G4A—asthma	0.0001	0.000173	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—asthma	9.93e-05	0.000172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CSF2—asthma	9.89e-05	0.000171	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BDKRB2—asthma	9.78e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—asthma	9.76e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—asthma	9.74e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SMAD3—asthma	9.63e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADCY2—asthma	9.46e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL3—asthma	9.43e-05	0.000163	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ITPR1—asthma	9.39e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—asthma	9.26e-05	0.00016	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RHOA—asthma	9.25e-05	0.00016	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PPP2CA—asthma	9.21e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—asthma	9.04e-05	0.000156	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CD86—asthma	8.94e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—asthma	8.94e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2RA—asthma	8.91e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KNG1—asthma	8.9e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EDN1—asthma	8.87e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—asthma	8.87e-05	0.000153	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—asthma	8.85e-05	0.000153	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGTR1—asthma	8.84e-05	0.000153	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—C3—asthma	8.84e-05	0.000153	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—asthma	8.8e-05	0.000152	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLA2G4A—asthma	8.77e-05	0.000152	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—asthma	8.68e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CSF2—asthma	8.67e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6R—asthma	8.65e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—asthma	8.64e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—RHOA—asthma	8.6e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PDGFB—asthma	8.6e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—asthma	8.54e-05	0.000148	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NTRK1—asthma	8.48e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SMAD3—asthma	8.44e-05	0.000146	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—asthma	8.39e-05	0.000145	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LEP—asthma	8.23e-05	0.000142	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—asthma	8.12e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PPP2CA—asthma	8.08e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ITPR1—asthma	7.94e-05	0.000137	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—asthma	7.93e-05	0.000137	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2RA—asthma	7.82e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RHOA—asthma	7.81e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FN1—asthma	7.76e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—asthma	7.76e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—C3—asthma	7.75e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CD86—asthma	7.56e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—asthma	7.55e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PDGFB—asthma	7.54e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EDN1—asthma	7.5e-05	0.00013	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—asthma	7.44e-05	0.000129	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLA2G4A—asthma	7.41e-05	0.000128	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CSF2—asthma	7.33e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—asthma	7.22e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LEP—asthma	7.22e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SMAD3—asthma	7.13e-05	0.000123	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—asthma	7.07e-05	0.000122	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—asthma	6.92e-05	0.00012	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6R—asthma	6.9e-05	0.000119	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—asthma	6.86e-05	0.000119	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PPP2CA—asthma	6.83e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FN1—asthma	6.8e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—EGFR—asthma	6.77e-05	0.000117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—asthma	6.7e-05	0.000116	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2RA—asthma	6.61e-05	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—asthma	6.56e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C3—asthma	6.55e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SERPINE1—asthma	6.46e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDGFB—asthma	6.38e-05	0.00011	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RHOA—asthma	6.23e-05	0.000108	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—asthma	6.2e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOS3—asthma	6.16e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LEP—asthma	6.1e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—asthma	6.06e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6R—asthma	6.05e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—EGFR—asthma	5.93e-05	0.000103	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FN1—asthma	5.75e-05	9.95e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SERPINE1—asthma	5.66e-05	9.8e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—asthma	5.47e-05	9.46e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RHOA—asthma	5.46e-05	9.45e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOS3—asthma	5.41e-05	9.35e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—asthma	5.24e-05	9.06e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—asthma	5.23e-05	9.04e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—asthma	5.2e-05	9e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—asthma	5.13e-05	8.87e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6R—asthma	5.11e-05	8.84e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—EGFR—asthma	5.01e-05	8.68e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—asthma	4.95e-05	8.56e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTEN—asthma	4.92e-05	8.51e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—asthma	4.79e-05	8.3e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SERPINE1—asthma	4.78e-05	8.28e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RHOA—asthma	4.62e-05	7.99e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—asthma	4.58e-05	7.93e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOS3—asthma	4.57e-05	7.9e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—asthma	4.56e-05	7.89e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—asthma	4.44e-05	7.68e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—asthma	4.4e-05	7.61e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—asthma	4.34e-05	7.5e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTEN—asthma	4.31e-05	7.46e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—asthma	4.08e-05	7.05e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—asthma	4.05e-05	7.01e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—EGFR—asthma	4e-05	6.92e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—asthma	3.89e-05	6.74e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—asthma	3.87e-05	6.7e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—asthma	3.86e-05	6.67e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—asthma	3.85e-05	6.67e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—asthma	3.67e-05	6.34e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTEN—asthma	3.64e-05	6.3e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—asthma	3.57e-05	6.18e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—EGFR—asthma	3.5e-05	6.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—asthma	3.29e-05	5.69e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—asthma	3.26e-05	5.64e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—asthma	3.07e-05	5.31e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—asthma	3.02e-05	5.23e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—EGFR—asthma	2.96e-05	5.12e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—asthma	2.69e-05	4.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—asthma	2.28e-05	3.94e-05	CbGpPWpGaD
